Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment
Background Coronavirus infectious disease 2019 (COVID-19) has developed into a global pandemic. It is essential to investigate the clinical characteristics of COVID-19 and uncover potential risk factors for severe disease to reduce the overall mortality rate of COVID-19. Methods Sixty-one critical C...
| Autor principal: | |
|---|---|
| Formato: | Published Article |
| Publicado: |
2020-04-28
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1101/2020.04.23.20076851 https://hdl.handle.net/20.500.12663/1610 |